Abstract:Through the combined use of (18)F-fallypride positron emission tomography and magnetic resonance imaging this study examined the neural mechanisms underlying the attentional deficits associated with attention deficit/hyperactivity disorder and their potential reversal with a single therapeutic dose of methylphenidate. Sixteen adult patients with attention deficit/hyperactivity disorder and 16 matched healthy control subjects were positron emission tomography and magnetic resonance imaging scanned and tested on a computerized sustained attention task after oral methylphenidate (0.5 mg/kg) and placebo administration in a within-subject, double-blind, cross-over design. Although patients with attention deficit/hyperactivity disorder as a group showed significant attentional deficits and reduced grey matter volume in fronto-striato-cerebellar and limbic networks, they had equivalent D2/D3 receptor availability and equivalent increases in endogenous dopamine after methylphenidate treatment to that observed in healthy control subjects. However, poor attentional performers drawn from both the attention deficit/hyperactivity disorder and the control groups had significantly reduced left caudate dopamine activity. Methylphenidate significantly increased dopamine levels in all nigro-striatal regions, thereby normalizing dopamine levels in the left caudate in low performers. Behaviourally, methylphenidate improved sustained attention in a baseline performance-dependent manner, irrespective of diagnosis. This finding was accompanied by an equally performance-dependent effect of the drug on dopamine release in the midbrain, whereby low performers showed reduced dopamine release in this region. Collectively, these findings support a dimensional model of attentional deficits and underlying nigro-striatal dopaminergic mechanisms of attention deficit/hyperactivity disorder that extends into the healthy population. Moreover, they confer midbrain dopamine autoreceptors a hitherto neglected role in the therapeutic effects of oral methylphenidate in attention deficit/hyperactivity disorder. The absence of significant case-control differences in D2/D3 receptor availability (despite the observed relationships between dopamine activity and attention) suggests that dopamine dysregulation per se is unlikely to be the primary cause underlying attention deficit/hyperactivity disorder pathology in adults. This conclusion is reinforced by evidence of neuroanatomical changes in the same set of patients with attention deficit/hyperactivity disorder.

The Effects of First-Dose Methylphenidate on the Neural Signatures of Visual Selective Attention in Children with Attention-Deficit/hyperactivity Disorder

Effects of Extended-released Methylphenidate on the Inhibition of Children with Attention Deficit Hyperactivity Disorder

Neural markers of methylphenidate response in children with attention deficit hyperactivity disorder and the impact on executive function

Overactivated Contextual Visual Perception and Response to a Single Dose of Methylphenidate in Children with ADHD.

The effect of a single dose of methylphenidate on attention in children and adolescents with ADHD and comorbid Oppositional Defiant Disorder

The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder

Methylphenidate Normalizes Resting-State Brain Dysfunction in Boys With Attention Deficit Hyperactivity Disorder

Verbal Working Memory-Related Functional Connectivity Alterations in Boys with Attention-Deficit/hyperactivity Disorder and the Effects of Methylphenidate.

Functional Near-Infrared Spectroscopy Study on Inhibitory Control Ability of Children with Attention Deficit Hyperactivity Disorder with Methylphenidate Therapy: an Experimental, Longitudinal, and Neuroimaging Study

Effects of methylphenidate on resting-state brain activity in normal adults: an fMRI study

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder

Effect of methylphenidate on functional controllability: a preliminary study in medication-naïve children with ADHD

Methylphenidate normalizes aberrant beta oscillations and reduces alpha power during retention in children with ADHD

Changes of Visual P300 and Mismatch Negativity of Patients with Attention Deficit Hyperactivity Disorder before and after Methylphenidate Treatment

The influence of methylphenidate on the power spectrum of ADHD children - an MEG study

Effects of Methylphenidate on Behavior and Ultrastructures of Synapse in Prefrontal Codex of Spontaneous Hypertension Rats

Functional Mri in Attention-Deficit Hyperactivity Disorder: Evidence for Hypofrontality

[Changes of the Alpha Competitive Structure after Administration of Single Dose Methylphenidate in Different Subtypes of Attention Deficit Hyperactivity Disorder Boys].

A Positron Emission Tomography Study of Nigro-Striatal Dopaminergic Mechanisms Underlying Attention: Implications for ADHD and Its Treatment.

Effect of short-term methylphenidate on social impairment in children with attention deficit/hyperactivity disorder: systematic review

Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD